EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Management of vancomycin‐resistant Enterococci and daptomycin‐resistant Enterococci infections in liver transplant recipients in a single academic center

Aldo Barajas-Ochoa, Olivia Hess, Tucker Smith, Matthew Ambrosio, Megan Morales, Idris Yakubu iD, Lora Thomas iD, David Bruno iD, Nicole Vissichelli iD

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Aldo Barajas-Ochoa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Virginia Commonwealth University, Richmond, Virginia, USA. Hauptthemen laut MEDLINE: Daptomycin, Liver Transplantation, Anti-Bacterial Agents, Vancomycin-Resistant Enterococci. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vancomycin‐resistant Enterococci (VRE) infections cause significant morbidity and mortality in liver transplant (LT) recipients. Management is challenging, especially in the setting of daptomycin resistance (DR).

Methods

Single‐center retrospective review of patients who underwent LT between January 1, 2020, and December 31, 2022, and developed VRE infections. Descriptive statistics were used and Kaplan‐Meier curves estimated freedom from treatment failure and survival.

Results

Forty‐two patients (median age 58; 64% female; 67% white) were included. Alcohol‐related cirrhosis (48%) and metabolic dysfunction‐associated steatohepatitis (31%) were the most common indications for LT, and most were from deceased donors (86%). VRE infection occurred at a median of 21 days after LT, and 16% had known prior VRE colonization. Common infection sites were blood (45%, n = 19), intraabdominal (36%, n = 15), and urine (36%, n = 15). Most were initially treated with daptomycin alone (64%) or in combination with other agents (21%); 7% received linezolid alone. Twelve (29%) developed breakthrough infections during treatment and 11 (26%) had recurrent infections after discontinuation of treatment. All‐cause mortality was 36% ( n = 15) at a median of 90 days after VRE infection diagnosis and was nearly twice as high in patients with DR (63%).

Conclusion

VRE infection in LT recipients relapsed or recurred in over 25%. Mortality was high, especially in cases with DR. More data is needed to establish an optimal treatment approach, particularly for relapse and DR. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DaptomycinLiver TransplantationAnti-Bacterial AgentsVancomycin-Resistant EnterococciGram-Positive Bacterial InfectionsHumansFemaleMaleMiddle AgedRetrospective StudiesAgedAdultVancomycinLinezolidTransplant RecipientsAcademic Medical Centers

Stichwörter der Autor:innen

eravacyclineliver transplantvancomycin‐resistant Enterococci

Substanzen

DaptomycinAnti-Bacterial AgentsVancomycinLinezolid

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Department of Surgery, Division of Transplant Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
  • Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Department of Surgery, Division of Transplant Surgery, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID-Profile: Idris Yakubu, Lora Thomas, David Bruno, Nicole Vissichelli

Zitieren

APA

Barajas-Ochoa, A., Hess, O., Smith, T., Ambrosio, M., Morales, M., Yakubu, I., Thomas, L., Bruno, D., & Vissichelli, N. (2024). Management of vancomycin‐resistant Enterococci and daptomycin‐resistant Enterococci infections in liver transplant recipients in a single academic center. Transplant Infectious Disease. https://doi.org/10.1111/tid.14387

Vancouver

Barajas-Ochoa A, Hess O, Smith T, Ambrosio M, Morales M, Yakubu I, et al. Management of vancomycin‐resistant Enterococci and daptomycin‐resistant Enterococci infections in liver transplant recipients in a single academic center. Transplant Infectious Disease. 2024. doi:10.1111/tid.14387

BibTeX
@article{BarajasOchoa2024,
  author = {Barajas-Ochoa, Aldo and Hess, Olivia and Smith, Tucker and Ambrosio, Matthew and Morales, Megan and Yakubu, Idris and Thomas, Lora and Bruno, David and Vissichelli, Nicole},
  title = {Management of vancomycin‐resistant Enterococci and daptomycin‐resistant Enterococci infections in liver transplant recipients in a single academic center},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14387}
}
Kostenlos starten →